HIV vaccine being developed by Johnson & Johnson fails clinical trial
Jan. 18, 2023... The National Institute of Allergy and Infectious Diseases reported Wednesday that a phase 3 clinical trial of an HIV vaccine was stopped because the vaccine was ineffective at preventing infection.